Minimal molecular alteration in PI3KCA, FGFR1 and CCND1 is associated with increased benefit from everolimus in hormone receptor-positive, HER2-advanced breast cancer: Insights from the BOLERO-2 trial Meeting Abstract
| Authors: | Baselga, J.; Piccart, M.; Gnant, M.; Burris, H.; Chen, D.; Robinson, D.; Huang, A.; McDonald, R.; Taran, T.; Hortobagyi, G. |
| Abstract Title: | Minimal molecular alteration in PI3KCA, FGFR1 and CCND1 is associated with increased benefit from everolimus in hormone receptor-positive, HER2-advanced breast cancer: Insights from the BOLERO-2 trial |
| Meeting Title: | 17th European Cancer Conference (ECCO 17) |
| Journal Title: | European Journal of Cancer |
| Volume: | 49 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2013 Sep 27-Oct 1 |
| Meeting Location: | Amsterdam, Netherlands |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2013-09-01 |
| Start Page: | S404 |
| End Page: | S405 |
| Language: | English |
| ACCESSION: | WOS:000326843602466 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(13)70062-5 |
| Notes: | Meeting Abstract: 1867 -- 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity -- SEP 27-OCT 01, 2013 -- Amsterdam, NETHERLANDS -- Source: Wos |
